| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
1994-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480f7c54fbd8a192ab8827c550eaa62d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae6557bdf2c2925005082f6878a6a141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e3eb84fa571a097d504f0bf2e50e4d1 |
| publicationDate |
2002-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0799224-B1 |
| titleOfInvention |
Quinoxalines and drugs prepared therefrom |
| abstract |
The invention concerns quinoxaline-2,3-(1H, 4H)-diones of general formula (I) and their tautomeric and enantiomeric forms as well as their physiologically tolerated salts, the variables R, R?1 and R2¿ having the meanings given in claim 1. The invention further concerns drugs prepared therefrom. |
| priorityDate |
1993-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |